Generics - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

26 to 50 of 566 results

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

05-12-2013

Eyal Desheh, acting president and chief executive of the world’s largest generics maker Teva (NYSE:…

CopaxoneGenericsInterviewsManagementPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

Japan’s MoF seen as another opponent to premium system

Japan’s MoF seen as another opponent to premium system

29-10-2013

The Budget Bureau of Japan’s Ministry of Finance, in a meeting of the Fiscal System Council last week,…

Asia-PacificGenericsPharmaceuticalPricing

Increase in chronic and lifestyle-associated diseases to Brazil market sales

Increase in chronic and lifestyle-associated diseases to Brazil market sales

11-10-2013

Brazil has emerged as a manufacturing hub for pharmaceutical and biotechnology companies, with the pharma…

GenericsPharmaceuticalSouth America

Teva gets favorable Copaxone patent ruling in Netherlands

Teva gets favorable Copaxone patent ruling in Netherlands

04-10-2013

The District Court of the Hague has issued a favorable ruling for Teva Pharmaceutical Industries in a…

EuropeGenericsLegalNeurologicalPatentsPharmaceutical

Modest growth forecast for Greek pharma market, despite unstable economy

04-10-2013

The growing prevalence of chronic diseases and an increasing elderly population will boost the Greek…

EuropeGenericsHealthcareMarkets & MarketingPharmaceuticalPricing

Promising outcome of EU platform on access to medicines in Africa

17-09-2013

The Platform on Access to Medicines in Developing Countries with a Focus on Africa took a step forward…

EuropeFinancialGenericsHealthcarePharmaceuticalRest of the World

Increase of Japan's medical expenditure slowed to 1.7% in 2012

17-09-2013

The Japanese Ministry of Health, Labor and Welfare (MHLW) reported approximate medical expenditure (AME)…

Asia-PacificFinancialGenericsHealthcarePharmaceutical

Canada's Health Minister sets out plan to help reduce impact of drug shortages

16-09-2013

A national protocol for the public notification of drug shortages and a toolkit that identifies steps…

GenericsHealthcareNorth AmericaPharmaceuticalRegulation

Advance Pharmaceutical to invest $25 million in building plant in Russia

13-09-2013

USA-based privately-held drugmaker Advance Pharmaceutical Inc is considering establishing a facility…

Advance PharmaceuticalEuropeFinancialGenericsPharmaceuticalProduction

Adcock Ingram agrees takeover terms with CFR

12-09-2013

Adcock Ingram (AIP: SP), one of South Africa's largest drugmakers, has provided further details of the…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Avanir Pharma patent settlement with Wockhardt

08-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with the US unit…

Avanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceuticalWockhardt

Bayer in settlement over Cipro pricing

04-09-2013

A partial settlement has been reached in a US class action law suit involving the prescription antibiotic…

Antibiotics and Infectious diseasesBayerCiproGenericsLegalNorth AmericaPharmaceuticalPricing

Avanir Pharma settles Nuedexta patent litigation with Actavis

03-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) says that it has entered into a settlement agreement…

ActavisAvanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceutical

UNITAID helps accessing quality drugs at affordable prices

03-09-2013

At an interactive session with Indian pharmaceuticals and diagnostics industry leaders organized by the…

Asia-PacificGenericsGlobalHealthcarePharmaceuticalPricing

Russian billionaire to acquire control of Veropharm

03-09-2013

Roman Avdeev, a well-known Russian banker and one of the country's richest people, has agreed to acquire…

GenericsMergers & AcquisitionsPharmaceuticalVeropharm

Lundbeck files appeal over EC pay-for-delay fine

02-09-2013

Denmark-based CNS specialist drugmaker Lundbeck (LUND: CO) has filed its appeal against the European…

citalopramEuropeFinancialGenericsLegalLundbeckPharmaceutical

Teva to drop development of Nuvigil in bipolar 1 disorder

31-08-2013

Israel-based leading generics company Teva Pharmaceutical Industries (NYSE: TEVA) has released disappointing…

armodafinilCephalonGenericsNeurologicalNuvigilPharmaceuticalResearchTeva Pharmaceutical Industries

Endo Health expends $225 million on generic acquisition

29-08-2013

USA-based specialty health care company Endo Health Solutions (Nasdaq: ENDP) says that that its Qualitest…

Boca PharmacalEndo Health SolutionsGenericsMergers & AcquisitionsPharmaceutical

Pharmstandard commits $30 million to Argos Therapeutics; post 1st-half results

28-08-2013

Russia's largest drugmaker Pharmstandard (PHST: RU) that its subsidiary Pharmstandard International.(Luxembourg)…

AGS-003Argos TherapeuticsFinancialGenericsOncologyPharmaceuticalPharmstandardResearch

Aid group urges countries not to trade away health as TPP negotiations intensify

23-08-2013

The far-reaching Trans-Pacific Partnership Agreement (TPP) should be a force for improving health outcomes…

GenericsGlobalPatentsPharmaceuticalPricing

Horizon Pharma in Duexis patent settlement

22-08-2013

Horizon Pharma (Nasdaq: HZNP) says it has entered into settlement and license agreements with Par Pharmaceutical…

Anti-Arthritics/RheumaticsDuexisGenericsHorizon PharmaNorth AmericaPar PharmaceuticalPatentsPharmaceutical

US FDA accepts Pennsaid 2% NDA for review

22-08-2013

The US Food and Drug Administration has accepted for filing US drugmaker Mallinckrodt's (NYSE: MNK) New…

Anti-Arthritics/RheumaticsGenericsMallinckrodtNorth AmericaNuvo ResearchPennsaidPharmaceuticalRegulation

26 to 50 of 566 results

Back to top